Lanzhou Foci Pharmaceutical Co Ltd (002644) — Financial Flexibility Index
Lanzhou Foci Pharmaceutical Co Ltd (002644) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of CN¥77.00 Million (operating CF CN¥75.62 Million minus capex CN¥1.38 Million) represents 0% of total liabilities (CN¥678.01 Million). Check cash flow reinvestment rate of Lanzhou Foci Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lanzhou Foci Pharmaceutical Co Ltd Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Lanzhou Foci Pharmaceutical Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see Lanzhou Foci Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)
Year-by-year free cash flow to debt coverage for Lanzhou Foci Pharmaceutical Co Ltd. Explore how well can Lanzhou Foci Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.08x | CN¥52.27 Million | CN¥38.98 Million | CN¥654.81 Million | ▼ -31.2% |
| 2023 | 0.12x | CN¥88.19 Million | CN¥65.71 Million | CN¥759.67 Million | ▼ -13.1% |
| 2022 | 0.13x | CN¥113.88 Million | CN¥72.37 Million | CN¥852.60 Million | ▲ +116.7% |
| 2021 | 0.06x | CN¥44.66 Million | CN¥11.85 Million | CN¥724.59 Million | ▼ -73.4% |
| 2020 | 0.23x | CN¥185.47 Million | CN¥62.89 Million | CN¥800.08 Million | ▲ +47.0% |
| 2019 | 0.16x | CN¥140.97 Million | CN¥47.82 Million | CN¥893.78 Million | ▼ -42.6% |
| 2018 | 0.27x | CN¥297.78 Million | CN¥36.66 Million | CN¥1.08 Billion | ▼ -46.5% |
| 2017 | 0.51x | CN¥509.19 Million | CN¥66.42 Million | CN¥990.68 Million | ▲ +18.4% |
| 2016 | 0.43x | CN¥323.90 Million | CN¥56.90 Million | CN¥746.13 Million | ▼ -51.8% |
| 2015 | 0.90x | CN¥116.03 Million | CN¥64.11 Million | CN¥128.77 Million | ▲ +97.5% |
| 2014 | 0.46x | CN¥142.11 Million | CN¥93.75 Million | CN¥311.40 Million | ▲ +21.0% |
| 2013 | 0.38x | CN¥75.34 Million | CN¥-10.47 Million | CN¥199.70 Million | ▼ -45.9% |
| 2012 | 0.70x | CN¥102.76 Million | CN¥-11.02 Million | CN¥147.38 Million | ▲ +74.6% |
| 2011 | 0.40x | CN¥72.35 Million | CN¥2.43 Million | CN¥181.14 Million | ▼ -33.6% |
| 2010 | 0.60x | CN¥78.03 Million | CN¥56.18 Million | CN¥129.70 Million | ▲ +280.5% |
| 2009 | 0.16x | CN¥26.74 Million | CN¥3.46 Million | CN¥169.09 Million | ▲ +315.4% |
| 2008 | 0.04x | CN¥6.99 Million | CN¥602.56K | CN¥183.70 Million | ▼ -97.1% |
| 2007 | 1.29x | CN¥213.16 Million | CN¥105.61 Million | CN¥164.72 Million | — |